Comparison of Volume-controlled and Pressure-controlled Ventilation in Clasp-knife Position
1 other identifier
interventional
60
1 country
1
Brief Summary
Carbon dioxide (CO2) pneumoperitoneum and clasp-knife positioning are commonly used to improve surgical access during robot-assisted laparoscopic urological surgery. However, these methods are sometimes associated with several unwanted cardiopulmonary effects such as increased mean arterial pressure, decreased pulmonary compliance and functional residual capacity, increased peak inspiratory pressure, and respiratory acidosis in association with hypercarbia. Volume-controlled ventilation (VCV) is the most commonly used method of ventilation during general anesthesia. It provides fixed minute ventilation and pulmonary resistance, which affect airway pressure. In pressure-controlled ventilation (PCV), constant inspiratory airway pressure can be achieved by decelerating the flow. However, minute ventilation is not fixed . CO2 pneumoperitoneum in the clasp-knife positioning can influence hemodynamic variables, including blood pressure, heart rate, and cardiac output. This is because changes in airway pressure affect intrathoracic pressure and the function of the heart itself. In this randomized study, we investigated the effects of VCV and PCV on peak inspiratory pressure during robot-assisted laparoscopic urological surgery involving CO2 pneumoperitoneum in the clasp-knife position.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2023
CompletedFirst Submitted
Initial submission to the registry
March 8, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedSeptember 28, 2023
September 1, 2023
4 months
March 8, 2023
September 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Check the patient's ventilation effect at a specific time
we recorded the patients' peak inspiratory pressure
T1(15 minutes after induction of anesthesia)
Check the patient's ventilation effect at a specific time
we recorded the patients' peak inspiratory pressure
T2(15 minutes after position was changed)
Check the patient's ventilation effect at a specific time
we recorded the patients' peak inspiratory pressure
T3(30 minutes after pneumoperitoneum was established)
Check the patient's ventilation effect at a specific time
we recorded the patients' peak inspiratory pressure
T4(60 minutes after pneumoperitoneum was established)
Check the patient's ventilation effect at a specific time
we recorded the patients' peak inspiratory pressure
T5(15 minutes after pneumoperitoneum was released)
Study Arms (2)
VCV group
EXPERIMENTALFor patients assigned in this group, after standard anesthesia, in which the following drugs were used (midazolam 0.05 mg / kg;propofol 1.5-2.5 mg / kg; sufentanil 0.3-0.5 μg / kg; and cisatracurium0.2-0.3 mg / kg), their mechanical ventilation mode was adjusted to the VCV mode.
PCV group
EXPERIMENTALFor patients assigned in this group, after standard anesthesia, in which the following drugs were used (midazolam 0.05 mg / kg;propofol 1.5-2.5 mg / kg; sufentanil 0.3-0.5 μg / kg; and cisatracurium0.2-0.3 mg / kg), their mechanical ventilation mode was adjusted to the PCV mode.
Interventions
Hemodynamic variables, respiratory variables and arterial blood gas were measured and recorded 15 minutes after induction of anesthesia (T1), 15 minutes after establishment of a folding knife position (T2), 30 and 60 minutes after CO2 pneumoconiosis (T3 and T4), and 15 minutes after pneumoconiosis (T5). Hemodynamic variables measured included mean arterial pressure , heart rate , cardiac output, cardiac index, stroke volume index and stroke volume variation. Breathing variables include tidal volume, minute ventilation , respiratory rate , airway frontal pressure , mean airway pressure , plateaus airway pressure , peripheral oxygen saturation , oxygen saturation , and oxygen response . Arterial blood gas variables include pH value, arterial carbon dioxide, arterial oxygen pressure , alkali surplus , alveolar oxygen pressure , and bicarbonate of soda ion concentration .
Eligibility Criteria
You may qualify if:
- Patients undergoing urological surgery in clasp-knife position
- between the age of 18 and 65
- America Society of Anesthesiologist Grades I-II.
You may not qualify if:
- Morbid obesity
- systolic blood pressure \< 90 mmHg)
- heart rate \< 60 beats per minute or \> 100 beats per minute
- peripheral blood oxygen saturation \< 90%
- Complicated with severe liver and kidney injury.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cai Xinyuan
Guangzhou, Guangdong, 510060, China
Study Officials
- PRINCIPAL INVESTIGATOR
Wenqian Lin
anesthesiology department of Sun Yat-sen University Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
March 8, 2023
First Posted
September 28, 2023
Study Start
October 15, 2022
Primary Completion
February 24, 2023
Study Completion
February 24, 2023
Last Updated
September 28, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share